Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
METHODS OF PREPARING ARIPIPRAZOLE CRYSTALLINE FORMS
No-Receipt date
2012-00066 - 10/01/2012
No-Filing date
20120400042 - 10/01/2012
No-Granting date
3076964 - 12/01/2012
No-EPO application date
04815093.2 - 16/12/2004
No-EPO granting date
1613598 - 19/10/2011
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
1/2012 - 05/03/2012
Expiration date
17/12/2024
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US530297 P16/12/2003/US
US533831 P30/12/2003/US
US618404 P13/10/2004/US
US618960 P14/10/2004/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07D 215/22
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
393219
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
5 BASEL STREET, P.O. BOX 3190
49131 PETAH TIQVA
ISRAEL
Inventors
Code
Firstname
Surname
930810
ARONHIME, JUDITH
930811
DOLITZKY, BEN-ZION
930812
LUVCHICK, ERAN
930813
HILDESHEIM, JEAN
930814
EISEN-NEVO, HAGIT
930815
IZSAK, REUVEN
Representatives
Code
Firstname
Surname
Address
Town
Zip
25
MARIA
ATHANASIADOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
5/29/2023 12:00:00 AM
Διάφορες Μεταβολές (70004)
ΑΡ.ΠΡΩΤ. 4430/10-02-2023 (ΛΙΣΤΑ) (ΑΡ.ΥΠΟΘ. 4654017/10-02-2023) ΔΝΥ. 440 ΚΩΔ.ΠΛΗΡ. 3464 ΑΡΣΗ & ΑΝΤΙΚΑΤΑΣΤΑΣΗ ΑΝΤΙΚΛΗΤΟΥ
1/8/2025 12:00:00 AM
Λήξη Προστασίας Τίτλων (79600)
79600
Payments history
20 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).